Hyku Biosciences Alternatives & Competitors

12 companies similar to Hyku Biosciences — Expanding the Boundaries of Covalent Therapies

Panthera Biopartners

An independent SMO partner providing the right patient, for the right trial, at the right...

126 Growth $10.00M

Preston, United Kingdom

Biotechnology Pharmaceutical

T-Therapeutics Ltd

Making T-Cell Receptor Biologics a Reality

62 Series A $48.00M

Cambridge, United Kingdom

Biotechnology Health Care

Exeliom Biosciences

Crossing the next frontier, to give you a fair chance to fight

8 Seed $36.80M

Dijon, France

Biopharma Biotechnology +2

Shape Therapeutics Inc.

The future of programmable RNA Medicines

32 Series B $147.50M

Seattle, United States

Biotechnology

Track all Hyku Biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare

61 Series Unknown $83.24M

Boston, United States

Biotechnology Health Care

LogicBio Therapeutics

Develops gene therapy vectors for previously incurable genetic and infectious diseases inc...

13 Acquired $139.00M

Lexington, United States

Biotechnology

Ro5

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.

12 Seed

London, United Kingdom

AI Biotechnology +3

Celogics

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutica...

Seattle, United States

Biotechnology Manufacturing

Clinic Hunter

Medical Tourism Marketplace

4 Unknown $50.00K

Lublin, Poland

Health Care

Baseimmune

Pioneering the next generation of active immunotherapies for chronic diseases

29 Series A $13.19M

London, United Kingdom

Biotechnology Health Care +1

Landos Biopharma, Inc.

28 Series B $70.00M

Blacksburg, United States

Biopharma Biotechnology +3

Onchilles Pharma

Developing drug candidates that have the potential to be broadly effective against a wide...

10 Series B $39.15M

San Diego, United States

Biopharma Biotechnology +1

About Hyku Biosciences

Expanding the Boundaries of Covalent Therapies

Services

Hyku Biosciences is focused on developing small molecule therapeutics that utilize a novel mechanism of covalent targeting to inactivate disease-causing proteins.

Target Customers

Pharmaceutical companies, healthcare institutions, researchers, and patients seeking innovative treatments for disease management.

Taxonomy

Covalent Therapies, Protein Targeting, Biotech Innovation, Drug Development, Amino Acid Binding, Disease Management, Selective Binding, Druggability Enhancement, Resistance Overcoming, Molecular Identification, Precision Medicine, Therapeutic Innovation

Business Model

B2B, B2D

Revenue Model

Licensing, Product Sales

Frequently Asked Questions

Top alternatives to Hyku Biosciences include Panthera Biopartners, T-Therapeutics Ltd, Exeliom Biosciences, Shape Therapeutics Inc., Vaxess Technologies. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Hyku Biosciences based on industry overlap, target customers, and business model.

Expanding the Boundaries of Covalent Therapies

Don't just read about them. Follow them.

BounceWatch watches Hyku Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Hyku Biosciences Profile Panthera Biopartners Alternatives T-Therapeutics Ltd Alternatives Exeliom Biosciences Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Hyku Biosciences on 11 Mar 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.